The Strategic Evolution of Patient Engagement in the NHS: The Post Wayfinder Era and Consolidation of the 'Digital Front Door'

Nelson Advisors
7 hours ago
13 min read

The strategic landscape of digital health in the National Health Service (NHS) is currently undergoing a foundational shift, characterised by a transition from a decentralised, market-led model of patient engagement to a highly centralised, state-curated "digital front door" model.

This evolution has been accelerated by the recent announcement that NHS England will cease central funding for the Wayfinder program by March 2026, a move that coincides with a broader cost-containment drive aimed at "dismantling" the established market for third-party patient engagement portals (PEPs).

While these developments have raised concerns regarding the sustainability of patient engagement, a rigorous analysis of the "10 Year Health Plan" and the accompanying productivity strategies reveals that engagement is not being abandoned but is instead being redefined as a core national utility delivered through the NHS App.

The future patient experience is being architected around a Single Patient Record (SPR) and a centralised Patient Care Aggregator (PCA), shifting the role of third-party suppliers from patient-facing platforms to back-end "engines" that facilitate standardised national workflows.

The Wayfinder Program: Success, Scale, and the Rationale for Centralisation

The Wayfinder program, formally designated as the Secondary Care Integration program, was established to address the fragmentation inherent in the NHS’s elective care pathways by providing patients with a unified view of their hospital referrals and appointments. By April 2025, the program had achieved substantial operational success, with 114 NHS trusts integrated into the service and over 130 million patient interactions recorded. The technical mechanism for this success was the Patient Care Aggregator (PCA), a centralised infrastructure that retrieves booking data from disparate secondary care systems and surfaces them within the NHS App.

Despite this momentum, the decision to end central funding for the Wayfinder national support program in March 2026 reflects a pivot in policy toward "direct integration". The government argues that the current model, which often requires trusts to procure third-party portals as intermediaries between their local Electronic Patient Records (EPRs) and the NHS App, is duplicative and unnecessarily expensive. By bypassing these intermediaries and wiring hospital systems directly into the national app, NHS England expects to achieve a standardised, "single pane of glass" experience for millions of citizens while simultaneously realising an estimated £11 Million in annual recurring savings.

Operational and Environmental Performance Metrics of the Wayfinder Infrastructure

The following table demonstrates the multi-dimensional benefits realized during the Wayfinder program's peak operational phase, highlighting why the underlying infrastructure is being retained even as the funding model shifts.

Metric Category	Performance Indicator	Realized or Forecast Benefit
Operational Efficiency	"Did Not Attend" (DNA) Rates	Major reductions demonstrated across 114 live trusts.
Systemic Impact	Waiting List Management	Estimated 3% improvement when core services are enabled.
Digital Engagement	App Interaction Volume	Wayfinder is consistently the second most-used service in the NHS App.
Sustainability	Carbon Reduction	97.8% reduction in emissions per appointment letter vs. paper.
Environmental Cost	CO2e per Appointment	Reduced from 72g (paper-based) to negligible (digital).
Resource Savings	Paper Reduction	Uptake avoids up to 30 million printed A4 sheets per year.

The environmental rationale, in particular, has become a key driver of digital policy. With the NHS contributing approximately 4-5% of total UK carbon emissions, the shift away from the 158 million physical letters sent annually—each costing the environment 72g of CO2e—is seen as essential for meeting the 2040 Net Zero commitment. The Wayfinder PCA itself was architected using "serverless" technologies and renewable-powered cloud hosting, ensuring its own operational carbon impact remains below national guidelines.

The Productivity Imperative and the 2025 Spending Review

The termination of central Wayfinder funding cannot be viewed in isolation from the 2025 Spending Review (SR) settlement, which mandates a 2% annual productivity improvement for the NHS over the next three years. This mandate triples the historical productivity growth average of 0.6% and is intended to unlock approximately £17 billion in savings by the end of the Parliament. The government’s "Productivity Plan Update" clarifies that technology is the primary lever for bridging the productivity gap created during the pandemic, where a 25% fall in efficiency was recorded.

To achieve these gains, NHS England is transitioning toward "digital-by-default" service models. This involves a "shift left"—moving care away from high-cost acute settings and toward community-based prevention and primary care. The centralising of patient engagement into the NHS App is a cornerstone of this strategy, as it allows for the automation of routine administrative tasks and the implementation of Patient-Initiated Follow-Up (PIFU) pathways at a national scale.

NHS England Financial Resource Limits and Productivity Targets (2024-2027)

The following table outlines the financial framework within which the digital transformation must occur, emphasizing the constraints on capital and revenue spend.

Financial Indicator	2024/25 Limit (£ Million)	Strategic Purpose
Total Revenue Resource Use	£196,269	Funding for ICBs, NHS England Group, and providers.
Total Capital Resource Use	£5,270	Investment in technology, estates, and medical equipment.
Productivity Capital	£3,400	Targeted tech/digital spend to unlock long-term savings.
Efficiency Target	2% (Year-on-Year)	Minimum required to sustain activity within agreed resources.
Acute Sector Performance	2.6% (H1 25/26)	Current trajectory of productivity improvement.

The focus for the 2026/27 financial year is on "progressive productivity," which involves radically reimagining care models through AI and remote monitoring. The board has emphasised that technology-derived benefits must be "owned and realised by the mainstream," necessitating an increased spend on "business change" and implementation rather than just procurement of software licenses.

Dismantling the Market: The End of Standalone Patient Portals?

The most controversial element of the current strategy is the explicit goal to "dismantle" the third-party PEP market. For over a decade, the NHS encouraged a competitive ecosystem of suppliers, including DrDoctor, Patients Know Best (PKB), and Induction Healthcare (Zesty), to innovate on top of local hospital systems. These platforms provided the "human touch" in digital health, competing on usability, messaging design, and clinical workflow optimisation.

However, the new "Digital Front Door" policy effectively puts these suppliers on notice. NHS England intends to withdraw supplier participation from "five core features" over the next three years: appointments, documents, notifications, and pre-visit questionnaires. In this future model, the patient-facing interface is exclusively the NHS App, while the local third-party systems are relegated to the role of back-end "engines".

Supplier Market Shifts and Strategic Pivots

Supplier	Historical Role	Strategic Pivot / Current Status
Induction Healthcare (Zesty)	Standalone PEP; 1m+ users.	Acquired by VitalHub in 2025; integration into multi-vertical asset portfolio.
Patients Know Best (PKB)	Patient-controlled health records.	Focus on "Citizen Ownership" and data integration via GP Connect APIs.
DrDoctor	Outpatient engagement; pre-op forms.	Pivot to "HybridOS"; integration of digital forms directly via NHS App DQM tool.
Accurx	GP messaging and AI-scribing.	Large-scale hospital rollout of AI tools; expansion into secondary care communication.
EBO	Conversational AI portals.	Use of NLP to automate two-way engagement surfaced through NHS App.

This shift has introduced significant "commercial risk" to the UK digital health ecosystem. Critics argue that bringing core functionality in-house could "chill investment" and leave the NHS dependent on a narrow set of large, incumbent EPR providers. Furthermore, there is a risk that "standardising the plumbing" without reimagining the user experience (UX) will result in a cheaper but less intuitive system that fails to meet modern consumer expectations.

The NHS App Roadmap (2025-2028): From Utility to "Doctor in Your Pocket"

As standalone portals face a forced migration to the back-end, the NHS App is being rapidly expanded to accommodate the full spectrum of patient engagement. With 34 million users already signed up and over 500 million logins recorded, the app is moving from a transactional utility to a "health companion". The 10 Year Health Plan, published in July 2025, envisions a future where the app serves as a "doctor in your pocket," leveraging AI and wearable data to provide proactive prevention rather than just reactive treatment.

Core Functional Enhancements and Upcoming Priorities

The roadmap for 2025-2026 reflects a prioritised effort to absorb the functions traditionally handled by localised PEPs.

Comprehensive Appointment Management: Following successful pilots at trusts like Rotherham, the app is enabling full management of Patient-Initiated Follow-Up (PIFU) pathways, allowing patients to request, cancel, or rebook their own follow-ups.
Digital Letters and Secondary Care Documents: The app's messaging inbox is being expanded to include digital letters from secondary care trusts, significantly reducing the reliance on paper and SMS.
Vaccination and Pharmacy Hub: A new vaccinations hub will bring together existing services, such as the National Booking Service, while prescription order tracking is being expanded to proxy users, such as parents of children aged 10 or younger.
Clinical Triage and AI Integration: AI-enabled triage is being scaled up to direct patients to the correct care setting, while tools like the "Dora" AI clinical assistant at Buckinghamshire are being used to automate routine clinical conversations.
Test Result Interpretation: Future updates will help users view detailed results and interpret changes between consecutive tests, moving beyond simple data access to actionable health literacy.

This functional expansion is supported by technical refinements, such as the reduction of login times by three seconds and the introduction of biometric login prompts (fingerprint, face, or iris) to reduce friction and improve security.

The Single Patient Record (SPR): The Foundation of the New Strategy

The success of the NHS App as a digital front door is entirely dependent on the successful implementation of the Single Patient Record (SPR), which was enshrined as a "foundational idea" in the 10 Year Health Plan in July 2025. The SPR is envisioned as a patient-owned, secure, and authoritative account of their medical history, consolidating data from GP surgeries, hospitals, genomics, and wearables.

However, the path to the SPR is fraught with technical and philosophical tensions. The NHS has chosen to build the SPR by connecting existing systems—such as EPRs, Shared Care Records, and the Federated Data Platform (FDP)—rather than replacing them. This "modular and iterative" approach is intended to de-risk the program, but it assumes a level of interoperability that has historically been elusive.

Comparative Framework: Standalone Portals vs. The Single Patient Record (SPR)

Feature	Legacy PEP / Portal Model	The Single Patient Record (SPR) Vision
Data Source	Local Trust PAS / EPR.	Unified national data core (EPR + GP + Genomics).
Data Ownership	Institutional (Trust-owned).	Citizen-owned / Patient-controlled.
User Access	Fragmented (Multiple logins).	Single identity (NHS Login) via the App.
Interoperability	Point-to-point (Brittle).	Standardized (FHIR / Open APIs).
Strategic Goal	Administrative convenience.	Personalised, predictive, preventative care.

Dr. Mohammad Al-Ubaydli (PKB) has noted that while the initial Request for Information (RFI) for the SPR emphasised patient ownership, there is a risk that "vested interests" may steer the project back toward a centralised, institutional model, which he argues would stifle innovation and reduce public trust. The philosophical shift from "clinician as keeper of the record" to "patient as integrator of their own care" is perhaps the most significant cultural change required by the 10-year plan.

Governance, ICB Restructuring and the Reintegration of NHS England

The digital transformation is occurring against a backdrop of radical organizational upheaval. In March 2025, Health Secretary Wes Streeting announced the abolition of NHS England as a separate "quango," bringing its functions directly back into the Department of Health and Social Care (DHSC). This move is intended to slash bureaucracy and ensure that every "single penny" of the £29 billion investment is redirected to the frontline.

Simultaneously, Integrated Care Boards (ICBs) have been mandated to cut their running costs by 50% by the third quarter of 2025/26. This has led to a wave of "clustering" and mergers, reducing the number of ICBs from 42 to approximately 27 in some regions. As ICBs transition into "strategic commissioners," they are expected to delegate more digital delivery to providers and "provider collaboratives".

Strategic Restructuring Timeline (2025-2027)

Date	Key Milestone	Organizational Impact
Q3 2025/26	ICB Running Cost Reduction (50%)	Transformation into lean strategic commissioners.
March 2026	End of Wayfinder National Support	Pivot to local trust/ICB responsibility for engagement.
April 2026	Formal Merger of London/SE ICBs	Creation of "West and North London ICB" (4.5m residents).
October 2026	Moorfields Oriel EPR Go-Live	Implementation of industry-first DQM tools in App.
April 2027	Second Round of ICB Mergers	Full alignment of ICBs with Strategic Authorities.
2028	NHS App as "Complete Front Door"	Replacement of two-thirds of outpatient appointments.

The emergence of "Advanced Foundation Trusts" (AFTs) provides a counterbalance to this centralization. Trusts that demonstrate high performance and digital maturity can apply for AFT status, granting them "strategic and operational autonomy" and greater financial flexibility. This may allow leading trusts, such as Imperial College or Moorfields, to continue driving innovation that eventually informs national standards.

Patient Engagement: Is it the "End" or a "New Beginning"?

The anxiety that the cessation of Wayfinder funding marks the "end for patient engagement" stem from a fear that digital transformation will be reduced to a "cost-containment line item". National Voices and other advocacy groups have warned that the value of "patient experience" could be lost in the transition, particularly for underserved communities who face digital exclusion.

However, the "Intelligent Patient Portal" (IPP) model and the shift toward "conversational AI" suggest that engagement is becoming more sophisticated, even if it is delivered through a single national app. Providers like EBO are using Behavioural Science to design two-way engagements that meet patients "where they are," resulting in engagement rates of over 65% and significant reductions in DNAs.

The Evolution of Engagement: Transactional vs. Transformational

The following data compares the traditional engagement model with the emerging digital-first approach.

Aspect	Transactional Portal Model	Transformational App Model
Communication	One-way (SMS/Email notifications).	Two-way (AI-enabled natural language).
Service Scope	Episode-specific (Single appointment).	Longitudinal (Prevention and self-care).
Integration	Standalone modules.	Deeply embedded in clinical pathways.
Data Input	Static forms (Multiple choice).	Dynamic, real-time (Wearables/DQM).
Patient Role	Managed consumer.	Empowered "Expert Digital Partner".

The 10-year plan explicitly shifts the focus from "treating sickness" to "preventing illness," which requires a far deeper level of engagement than simple appointment management. The goal is to standardise "clinical pathways" alongside the app, ensuring that digital tools are not "expensive irrelevances" but are instead fully integrated into clinical workflows.

Case Studies: Innovation in the Shadow of Centralisation

While the national strategy moves toward consolidation, specific trusts and partnerships continue to demonstrate the potential of the decentralised "innovation layer."

Moorfields and Lewisham & Greenwich: The DQM Revolution

Moorfields Eye Hospital, in collaboration with DrDoctor and NHS England, launched the Document and Questionnaire Management (DQM) tool in April 2025. This tool, which allows patients to complete pre-operative assessment forms directly via the NHS App, was subsequently rolled out at Lewisham and Greenwich NHS Trust. This "industry-first" integration represents the future of the PEP market: a third-party tool that delivers high-value clinical forms surfaced within the national app, saving thousands of hours of nursing time and millions of pounds in "unlocked activity".

Hull and Mid & South Essex: The PKB Integration

Hull University Teaching Hospitals has utilized the Patients Know Best (PKB) portal to deliver a 39% reduction in missed appointments through a combination of administrative and clinical engagement. In Mid and South Essex, PKB has been integrated with renal and maternity services, providing secure messaging, symptom tracking, and editable digital personalized care plans. These examples demonstrate that while the app is the "front door," the "rooms" behind that door are still being built by innovative suppliers who understand specific clinical pathways.

Humber Teaching: Wayfinder and BaRS Adoption

Humber Teaching NHS Foundation Trust has secured Wayfinder capital funding to lead TPP functionality development for eight partner organizations. This work focuses on the Booking and Referral Standard (BaRS) adoption and Single Patient Record interoperability, showing that local trusts are increasingly taking on regional leadership roles in the "digital-by-default" era.

Risks and Challenges: The Brittle Interfaces of Centralisation

The drive for centralization is not without significant technical and strategic risks. The assumption that the NHS can achieve "direct integration" from every EPR and PAS into the national app assumes a level of data quality and maturity that is not uniform across the system. Currently, 10-70% of trust technology estates are classified as "legacy," and clinicians lose 13.5 million hours a year to malfunctioning IT.

Critical Risks to the Digital Front Door Strategy

Interoperability Failure: Forcing a uniform pathway could expose "brittle interfaces," leading to system outages or data corruption if integration is poorly sequenced.
Commercial Cooling: Signalling that core features will be brought in-house could "chill investment" in the UK’s vibrant health-tech sector, reducing competition and leaving the NHS dependent on a narrow set of incumbents.
Digital Divide: The push for a "digital-by-default" model risks exacerbating health inequalities if the "front door" is inaccessible to those without devices or data.
Data Governance and Trust: The creation of the SPR and the use of the Federated Data Platform (FDP) require high levels of public trust. Concerns regarding "historic links" between technology partners and controversial figures have already raised governance alarms.

The board of NHS England has acknowledged that achieving "progressive productivity" will require a "different management approach," where increased spend is directed specifically toward "business change" to ensure that technology-derived benefits are actually realised on the frontline.

Conclusion: A Paradigm Shift in Patient Agency

The future of patient portals in the NHS is one of transformation rather than extinction. While the era of central funding for programs like Wayfinder is ending, the infrastructure they built is becoming the permanent foundation of a new, national digital utility. The "dismantling" of the third-party market is a strategic effort to consolidate the patient experience into a single, cohesive interface—the NHS App—and to redirect the savings into frontline care.

This marks a shift from a "managed" patient experience to an "empowered" one, underpinned by the Single Patient Record and the ambitious 10 Year Health Plan. The future patient experience will be characterised by:

Transactional Efficiency: Seamless booking, reordering, and tracking as standard.
Clinical Integration: Digital tools as an inseparable part of every care pathway.
Proactive Prevention: AI-led insights that move the NHS from a "National Sick Service" to a "National Health Service."
Sovereign Data: Patient ownership of medical records as the "bedrock" of a trust-based digital system.

The "end of Wayfinder" is, in reality, the beginning of the "Digital Front Door" as a mainstream reality. For suppliers, the challenge is to move up the value chain, providing the sophisticated clinical logic and data analytics that the national app needs to move beyond simple administration and into the era of predictive, personalized medicine.

For the NHS, the challenge is to manage this transition without losing the innovation, empathy, and local responsiveness that have characterised the best digital health initiatives of the last decade.

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech